Instructions for Authors
Instructions for Authors
Overview
Global Diagnostics and Therapeutics in Medicine publishes a wide variety of content, including Original Investigations, Reviews, Scholarly Communications, Commentaries and Correspondence, all centered on innovative studies that enhance patient outcomes across health disciplines.
To further streamline the submission process for authors, we have simplified our formatting requirements. Please review the following guidelines to help with manuscript preparation and submission.
Fast-Track Submission
The Fast-Track Submission option is available for all article types submitted to the journal that are high-impact or time-sensitive in nature. This pathway offers an accelerated timeline for peer review and publication.
Initial Decision within 3 days
Online publication within 7 days of acceptance
Notes
The fast-track submissions are selectively considered and must clearly justify the need for expedited review.
Manuscript Preparation
Cover Letter
Authors are not required to submit a cover letter for standard submissions, though they may include any relevant information they wish to share with the editors. However, a cover letter is required for Integrated Dual Manuscript Submissions. In such cases, the letter should clearly state the intent for dual submission and reference the titles of both manuscripts.
Response to Reviewers (for Revisions Only)
Authors are required to submit two versions of the revised manuscript: one with tracked changes and one as a clean copy without tracked changes. Additionally, authors must provide a detailed response letter addressing each of the reviewers’ comments.
Manuscript File
Manuscripts may be submitted in any review- friendly format as a Word document. For ease of peer review, we recommend organizing the manuscript in the following manner:
Title Page
Abstract and Key Words
Manuscript text
Data Sharing Statement
Declaration of Interests
Funding Sources
Author Contributions
Acknowledgments
References
Tables
Figure description
Figures
Supplementary Material
Supplementary data, tables, or figures should be clearly referenced in the manuscript and included within the main manuscript file. If the size or format does not allow inclusion, they should be submitted separately as supplementary material.
Submission Checklist
Before submission, authors should ensure that the following checklist has been completed
The corresponding author has been designated, with full contact details (email address, postal address, and phone number).
All required files, including keywords, figures, and tables, along with their legends, descriptions, and titles, have been uploaded.
All references cited in the text are included in the reference list and vice versa.
Permission for any copyrighted material, including content from online sources, has been obtained.
Manuscript Formatting
Title page
Ensure your title page includes the following details
Title
Provide a concise and informative title for your manuscript.
Author Information
List the names of all authors, their affiliations (including institution, department, city, and country), and clearly identify the corresponding author.
Address and Contact Information
Abstract
Provide a structured or unstructured abstract, depending on the submission type. For structured abstracts, use the subsections Background, Methods, Results, and Discussion. Word limits are determined by submission type. Only standard abbreviations should be used, and each must be spelled out in full at first mention. All information presented in the abstract must also be included in the main text or tables of the manuscript.
Keywords
Please provide a minimum of 3 keywords that can be used for indexing purposes.
Manuscript Text
The specific structure of articles may vary depending on the type of article, see the section types of articles.
Laboratory Values
Report laboratory values in SI units. Include normal reference ranges in parentheses following the values.
Abbreviations and Acronyms
Spell out abbreviations and acronyms fully the first time they appear in the text.
Statistical Reporting
Studies reporting significance levels must include sample size calculations and state the statistical power assumed when performing those calculations.
Statistical methods not widely published should be detailed in an appendix, with all non-standard tests referenced.
Report means with standard deviations as “mean (SD)” and means with standard errors as “mean ± SE.” For medians, provide both the interquartile range (IQR) and the full range.
Include significance levels for all comparisons, using P-values or confidence intervals.
When interpreting regression analyses, specify units for continuous variables and categories for discrete or ordinal variables.
For logistic and Cox regression analyses, also include the baseline or reference category for discrete or ordinal variables.
Report any losses to observation, such as dropouts or those lost to follow-up.
Consider using multiple imputation methods and assess whether data were missing at random and avoid using “last observation carried forward” methods.
Data Availability
Data availability statement should be placed toward the end of the manuscript right before the acknowledgment section” to “The data availability statement should be included at the end of the manuscript, immediately following the main text.
Declaration of Interests
Authors are required to disclose any financial interests, activities, personal relationships, or affiliations (excluding those listed on the title page) that could influence or appear to influence the content of the manuscript. This information should be included in the “Declaration of Interests” section immediately following the Data Availability Statement.
Examples of potential competing interests include:
Employment or leadership roles
Advisory or consulting relationships
Stock or equity ownership
Receipt of honoraria or speaking fees
Paid expert testimony
Patent applications or intellectual property rights
Research grants or other financial support
Royalties from publications or inventions
Board memberships or fiduciary roles
Authors must clearly state any competing interests to ensure transparency and maintain the integrity of the publication process. If no such interests exist, include the following statement:
“The authors have no conflicts of interest to declare.”
In addition, an official ICMJE Disclosure of Potential Conflicts of Interest form will be requested from all authors after acceptance of the paper.
Funding Sources
Authors must disclose any funding sources that supported the research or preparation of the article. If sponsors played a role in study design, data collection, analysis, interpretation, report writing, or the decision to submit the article for publication, this should be clearly stated. If the funding sources had no involvement, this should also be noted in your submission.
It is not necessary to provide detailed descriptions of programs or the type of grants, scholarships, or awards. When funding is provided through a block grant or other institutional resources, list the name of the institution or organization that supplied the funding.
If no funding was provided for the research, include the following statement in the title page:
“This research did not receive any funding.”
Acknowledgments
Authors should include an acknowledgments section to recognize individuals or organizations that provided intellectual assistance, technical support (including help with writing and editing), or special equipment and materials.
References
For convenience at submission, authors may submit references without proper formatting. If the manuscript is accepted, references will need to be presented in a consistent style or format. Essential details such as author names, journal or book title, chapter or article title, year of publication, volume numbers, and pagination must be included where applicable.
Tables
Refer to tables in the numerical order in which they appear in the manuscript. Tables should be text-only and not submitted as photographs. Each table must include a brief title, appropriate column headings, and legends. Explanatory notes should be placed in footnotes, not in the heading. If using data from another source, whether published or unpublished, obtain permission and provide full acknowledgment, including the name of the first author, reference number, and year. Authors are encouraged to submit non-essential tables as supplementary material.
Figure Description
Titles and captions for all figures should be provided as figure legends on a separate page at the end of the manuscript, following the reference list. Each legend should clearly explain the figure and define all symbols, abbreviations, and arrows used.
Figure Preparation Guidelines
General Requirements
Figures should be cited in consecutive numerical order in the text.
Submit figures at the end of the manuscript, with each figure placed on a separate page and the figure number clearly indicated at the top (e.g., Figure 1). If the manuscript file size is too large, large figures may be submitted separately. All figure images should be provided in JPEG or TIFF format with a minimum resolution of 300 dpi.
For State-of-the-Art Reviews, a Central Illustration is required. This single visual should summarize the key message of the manuscript, be labeled as “Central Illustration” (not as a numbered figure), and be accompanied by a legend. It must be original and not adapted from other sources.
A Visual Summary is required for case reports and should present the key teaching points or the essence of the case in a single figure. A detailed timeline may also be used to help readers understand the flow of the case.
a. Line Art (Black and White Graphics with No Shading)
Lines must be at least 0.1 mm (0.3 pt) wide.
Ensure all lines and lettering are clear and legible at the final size.
Scanned line drawings and line art in bitmap format should have a resolution of at least 1200 dpi.
For vector graphics, embed all fonts in the files.
b. Halftone Images (Photographs, Drawings, Paintings with Fine Shading)
Use scale bars to indicate magnification if applicable.
Halftone images should have a minimum resolution of 300 dpi.
c. Combination Art (Mix of Halftone and Line Art)
Ensure a minimum resolution of 600 dpi.
Maintain consistent lettering size throughout the artwork. Avoid significant type size variations within the same illustration.
Supplementary Material
Authors should include supplementary material embedded within the same manuscript file or, if the file size is excessive, submit it separately as a Word document. When submitted separately, the first page should contain the manuscript title, the first author’s name, and a numbered list of each supplementary element with its title. Supplementary material should be cited in the main manuscript, relevant to the content, and not duplicate information from the main text. It must be original, unpublished, and limited in quantity. Supplementary material will undergo the same editorial and peer review process as the main manuscript. If accepted, it will be posted online with the article. Authors are responsible for the accuracy and presentation of supplementary material, as it will not be edited or formatted.
Authorship and Contributions
To promote transparency and accountability in research, authors are encouraged to include contribution statements that specify each author’s role, particularly in fields where it is feasible to describe distinct contributions. Authorship contributions should be clearly defined according to the CRediT (Contributor Roles Taxonomy) classification, with each author’s role aligning with one or more of the following criteria:
Conceptualization, Data Curation, Formal Analysis, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, and Writing – Review and Editing.
For review articles, where specific statements may not apply, a statement should be included outlining who conceived the idea for the article, who conducted the literature search and data analysis, and who was responsible for drafting and/or critically revising the work.
Contributions should be detailed in the manuscript and listed before the acknowledgements statement.
Group Authorship
When authorship is attributed to a group (either alone or alongside individual authors), every member of the group must fulfill the full authorship criteria described above and complete the Authorship Forms. If all group members do not meet the criteria, the group must designate one or more individuals who meet the full authorship requirements and assume responsibility for the group. Group names should be listed at the end of the author byline and not interspersed with individual names.
For articles with a large number of authors (e.g., over 50), a lengthy author list may not fit within the byline of print or PDF versions. In such cases, a group byline will be used, with individual names listed at the end of the article. All authors will be indexed and searchable in bibliographic databases like PubMed.
Role of the Corresponding Author
A single corresponding author, or a designated coauthor (if the primary corresponding author is unavailable) will act as the main liaison with the editorial office throughout the submission and review stages.
Responsibilities include
Submitting the manuscript and all required documents.
Communicating with the editorial office during the review process.
Reviewing the edited manuscript and proofs upon acceptance.
Managing all post-publication communications and inquiries.
Requests for multiple corresponding authors will be considered, with a maximum of two allowed. If co-corresponding authors are approved, one will be designated as the primary contact and listed first in the corresponding author section.
Article Categories and Their Requirements
Original Investigation
Article Type
Description
Key Requirements
Randomized Clinical Trials
Controlled studies where participants are randomly assigned to intervention or control groups to evaluate the safety or efficacy of medical, surgical, behavioral, or lifestyle interventions. Designs may include parallel, crossover, cluster, and noninferiority trials.
Main text ≤3,000 words
Figures/Tables ≤6
References ≤30
Structured abstract ≤300 words
Trial registration, ID, protocol
Data Sharing Statement
Observational and Other Original Studies
Observational studies where associations between exposures and outcomes are examined without researcher intervention. Designs include cohort, case–control, and cross-sectional studies. Other forms of original research include diagnostic and prognostic studies that evaluate test accuracy or predict outcomes, quality improvement studies that aim to enhance care delivery, survey studies that capture knowledge, attitudes, or practices, and qualitative studies that provide in-depth insights into experiences and social phenomena.
Main text ≤3,000 words
Figures/Tables ≤6
References ≤30
Structured abstract ≤300 words
Data Sharing Statement
Meta-analyses
Quantitative synthesis of data from multiple studies to assess the strength and consistency of evidence on a specific research question.
Main text ≤3,000 words
Figures/Tables ≤6
References ≤30
Structured abstract ≤300 words
Data Sharing Statement
Brief Reports
Concise articles presenting original research or early findings, such as pilot studies or preliminary results. These reports include essential methodology and key outcomes.
Main text ≤1,500 words
Figures/Tables ≤2
References ≤10
Structured abstract ≤150 words
Data Sharing Statement
Research Letters
Short communications of original investigations, typically limited in scope and length. They present important preliminary findings, novel observations, or focused analyses that warrant rapid communication.
Main text ≤600 words
Figures/Tables ≤1
References ≤5
Data Sharing Statement
Reviews, Education and Scholarly Communication
Article Type
Description
Key Requirements
Systematic Reviews
Structured and comprehensive synthesis of existing research on a clearly defined question, using rigorous and transparent methods to identify, select, and critically appraise relevant studies.
Main text ≤3,000 words
Figures/Tables ≤6
References ≤50
Structured abstract ≤300 words
State of the Art Reviews
Summarize and analyze existing research on a specific topic, highlighting key findings, research gaps, and future directions.
Main text ≤5,000 words
Figures/Tables ≤6
References ≤80
Unstructured abstract ≤300 words
Central Illustration mandatory
Special Communications
Scholarly articles that address major issues in clinical practice, public health, health policy, or medical research. These pieces provide a thorough, evidence-based analysis that is well-structured, extensively referenced, and grounded in current knowledge.
Main text ≤2,000 words
Figures/Tables ≤3
References ≤30
Unstructured abstract ≤300 words
Case Reports
Detailed reports of unique or instructive clinical cases, with educational or diagnostic insights.
Main text ≤1,500 words
Figures/Tables ≤3 (including Visual Summary)
References ≤10
Structured abstract ≤150 words (Background, Case Summary, Discussion, Take-Home Messages)
Meeting Reports
Summaries of scientific conferences, highlighting new research findings and expert discussions.
Main text ≤1,000 words
Figures/Tables ≤3
References ≤10
Commentary and Perspectives
Article Type
Description
Key Requirements
Viewpoint
Brief articles presenting opinions or perspectives on key issues in medicine, public health, biomedical research, ethics, healthcare policy, or law. These pieces are not tied to specific research articles and aim to stimulate thought or discussion on timely or enduring topics.
Main text ≤1,500 words
References ≤10
Figures/Tables ≤2
From the Heart
Narrative pieces drawn from personal experiences in medicine, often reflecting on the patient-clinician relationship or other humanistic aspects of care. Submissions may also offer personal perspectives on broader challenges and themes within the medical profession.
Main text ≤1,000 words
References ≤10
Figures/Tables ≤2
Patient consent mandatory
Correspondence
Article Type
Description
Key Requirements
Letters to the Editors
A brief communication directed to the editor, typically responding to a recent article or discussing a topic of interest to the journal’s audience.
Main text ≤600 words
References ≤5
Figures/Tables ≤1
Response Letters
Responses from the authors of original articles to letters or comments submitted by readers.
Main text ≤600 words
References ≤5
Figures/Tables ≤1
Integrated Dual Manuscript Submission
Authors may submit a primary manuscript alongside a linked secondary or exploratory analysis. Both papers will be reviewed simultaneously and, if accepted, published with cross-referencing to ensure related findings are evaluated and disseminated together.
Submission Process
Each manuscript must be submitted separately in the Editorial Manager system.
The two manuscripts should be submitted within a short time frame, ideally on the same day, and no more than three days apart.
Cover letters for both manuscripts should clearly state the dual submission intent and reference the titles of both papers.
Where appropriate, each manuscript should reference its companion paper in the introduction or methods section.
Peer Review and Editorial Decisions
Both manuscripts will undergo parallel but independent peer review.
Editorial decisions for both papers will be communicated at the same time to ensure a coordinated outcome.
Acceptance of one manuscript does not guarantee acceptance of the other.
If only one paper is accepted, authors may revise and resubmit the other or submit it to a different journal.
Cross-Linking Upon Publication
If both papers are accepted, they will be published together and cross-linked online where appropriate.
Each article will include a reference and direct link to its companion piece in both the HTML and PDF versions.
Notes
Authors should explain the reason for dual submission in the cover letter for both manuscripts to assist editorial evaluation.
Editorial and Peer Review Process
Global Diagnostics and Therapeutics in Medicine uses a single-anonymized review system, where the identities of authors are disclosed to the reviewers, but the reviewers remain anonymous unless they choose to reveal their identity. Each manuscript is assigned to two expert reviewers, who provide evaluations and submit their reports.
Reviewers assess manuscripts based on criteria such as originality, clarity, data validity, soundness of conclusions, and relevance to the journal’s audience.
Confidentiality and Reviewer Conduct
Reviewers are required to disclose any personal, professional, or financial conflicts of interest. If a conflict arises, a substitute reviewer is appointed. Upon completing their review, reviewers are expected to destroy all copies of the manuscript.
Editorial Decision
Authors are informed of the editorial decision via email and can track the status of their manuscript through the journal’s online submission system. However, authors are prohibited from disclosing the submission status to anyone other than co- authors and contributors.
Accept
The manuscript is considered acceptable for publication, though minor edits may be needed.
Revise
The manuscript shows promise, but revisions are requested based on reviewer feedback.
Reject
The manuscript is not accepted for publication.
Addressing Reviewer Feedback
After receiving feedback from reviewers, authors may be given the opportunity to revise the manuscript according to their comments. The decision letter will outline the necessary changes and provide reviewer’s comments, along with instructions for returning the revised manuscript, including how to highlight changes and the deadline for submission.
When revising the manuscript and responding to peer review comments, authors should:
Express gratitude to the reviewers and editors for their time and feedback.
Address all comments from the reviewers.
Summarize major revisions in the response letter, followed by a detailed, point-by-point reply to each comment.
Conduct additional experiments or analyses recommended by reviewers, unless deemed unnecessary; if so, provide a clear rationale in the response letter.
Provide a respectful and scientifically grounded rebuttal to any disagreements, as this letter will be visible to reviewers in subsequent rounds.
Clearly differentiate between reviewer comments and responses in the letter.
Highlight major revisions in the manuscript using Microsoft Word’s Track Changes feature, in addition to describing changes in the response letter.
Appeals Process
Authors may appeal a rejection decision by submitting their intent to appeal within seven days of receiving the decision.
In the appeal, authors should provide a detailed explanation of why they disagree with the rejection, highlighting any errors in the decision or review process. The authors may include a point-by-point rebuttal addressing comments from the rejection email.
The appeal will be reviewed by an independent guest editor who was not involved in the original decision. This independent guest editor will evaluate the appeal along with the related documentation and will decide whether to uphold or overturn the rejection. Rejections will only be overturned if the independent editor determines that the original decision involved a significant error in judgment or process. The decision of the independent editor is final.
Ethical Considerations and Editorial Policies
Submission Declaration
By submitting an article to Global Diagnostics and Therapeutics in Medicine, the authors affirm that the work has not been previously published, except as a preprint, abstract, lecture, thesis, or registered report, and is not currently under review by any other journal. All authors must approve the submission, and any necessary permissions from relevant authorities must be secured. Upon acceptance, the article may not be published in the same format or any language, including electronically, without the explicit written consent of the copyright holder.
Human Subject Research Requirements
Researchers submitting studies involving human participants must obtain approval from an institutional review board (IRB) or equivalent ethics committee and provide documentation confirming this approval, with identifying information redacted. The study must adhere to ethical standards outlined in the Belmont Report or Declaration of Helsinki. Authors should identify the approving IRB or ethics committee, provide the approval number, and explain how informed consent was obtained or why it was not. If the study includes case details, personal information, or images of patients or other individuals, appropriate consents, permissions, and releases must be obtained. Written consents should be retained by the authors and submitted to the journal only if explicitly requested, such as in legal cases, with proof of consent provided when required. Personal details should only be included in the article or supplementary materials with written permission from the patient or, if applicable, their next of kin. For clinical trials, researchers must also include trial registration details, the study protocol, and CONSORT documentation.
Reporting Age
In the methods section, clearly define any age-related inclusion or exclusion criteria and stratify age groups based on their relevance to the disease, condition, or population (e.g., <5 years or >65 years). In the results section, present participant ages in aggregate form, such as mean with standard deviation (SD), median with interquartile range (IQR), or range.
Reporting Sex and Gender
Use “sex” to refer to biological factors and “gender” for gender identity or psychosocial/cultural aspects. Describe the methods used to gather information on sex and gender (e.g., self-reported, investigator-observed, or laboratory-tested) in the methods section. The results section should detail the distribution of study participants or samples, whether human, tissue, cell, or animal. Include data for all participants, not just the predominant category. For studies involving pregnancy, adhere to these guidelines and use terms like “pregnant participants” if gender identity was not assessed.
In research articles, ensure the study design, data analysis, results, and interpretation reflect all representative populations. Report the sex or gender of participants, specifying how these were defined and assessed. Whenever feasible, provide main outcomes by sex or gender. For non-research reports, use gender-neutral and sex-neutral terms to avoid bias and enhance clarity. Consult the Sex and Gender Equity in Research (SAGER) guidelines for further guidance.
Reporting Race and Ethnicity
In the methods section, clarify who identified participants’ race and ethnicity and specify the source of these classifications (e.g., self-report, investigator observation, database, electronic health record, survey instrument).
If race and ethnicity data were collected, explain the rationale behind their inclusion. If required by a funding agency, this should be mentioned. Prefer specific racial and ethnic categories over general terms whenever possible, and report the exact categories used in the study, acknowledging that these may vary depending on databases, surveys, funder requirements, and the geographic location of participants. Clearly define any categories grouped as “other,” and list categories alphabetically in both text and tables. Race and ethnicity data for the study population should be presented in the results section.
Data Sharing Statement
For all research reports, authors must include a Data Sharing Statement indicating whether the data will be shared. If data is shared, authors should specify what data (e.g., individual participant data, statistical code), when and how it will be available (e.g., link to repository), any usage restrictions, and permitted types of analysis. If data is not shared, authors should briefly explain why. This statement will appear as an online supplement linked to the published article. Authors may refer to the National Library of Medicine for a list of suitable public data repositories.
Declaration of Generative AI in Scientific Writing
Authors are required to disclose the use of generative AI in the scientific writing process when submitting their paper. This guidance pertains solely to the writing process and does not cover the use of AI tools for data analysis or generating insights as part of the research.
Generative AI and AI-assisted technologies should be used only to enhance the readability and language of the manuscript. These technologies must be employed under human supervision, with authors thoroughly reviewing and editing AI-generated content. Authors bear full responsibility for the final content of the manuscript.
AI and AI-assisted technologies should not be credited as authors or co-authors on the manuscript, as authorship entails responsibilities and tasks that can only be fulfilled by humans.
The use of generative AI in scientific writing must be disclosed by including a statement in the manuscript. This statement will also be included in the published work. If AI was not used, no such disclosure is necessary.
Post Acceptance and Publication
Publishing Options and Fees
Global Diagnostics and Therapeutics in Medicine offers an open-access model where authors or their funders are required to pay an APC upon acceptance to make the article freely accessible worldwide. This fee covers editorial services, production, and distribution.
The APC are as follows for each article type:
Full Length Original Articles, Reviews and Special Communications:
2,999 USD
Letter to Editors, Viewpoints, From the Heart, Brief Reports and Research Letters:
1,499 USD
Case Reports:
1,999 USD
Invited Editorials and Correspondence:
Free of Charge
Notes
All charges are exclusive of applicable taxes.
Licensing Options
CC BY-NC-ND (Attribution–NonCommercial–NoDerivatives 4.0 International): Allows sharing for non-commercial purposes with proper credit. Commercial use or adaptation requires additional permission.
CC BY (Attribution 4.0 International): Allows sharing, adaptation, and commercial use, provided the original authors are credited.
Authors retain copyright of their work, which is published under the license selected after acceptance of the manuscript. Please note that Article Processing Charges (APCs) are the same for both license types.
Authors should ensure that any third-party material included in their manuscript has appropriate permissions, as Creative Commons licensing applies only to the original content created by the authors.
Certain funding agencies require publication under a CC BY license; authors are responsible for selecting the license that ensures compliance with their funder’s policies.
Publishing Agreement
After acceptance, authors will be required to complete a publishing agreement. The corresponding author will receive a PDF of the agreement by email, which should be signed and returned as instructed. We encourage all authors to review our copyright policy and licensing agreement options in advance to understand their rights, as well as those of their employer or institution, under our open-access model.
Proof Correction
Corresponding authors will receive an email with a link to our online proofing system. This platform will allow you to annotate and correct text, comment on figures and tables, and respond to queries from our copy editor. This web-based service helps streamline the process and reduce errors.
The authors may choose to annotate and upload edits on the PDF version of your article if preferred. Proofing instructions and alternative methods will be provided in our email. Proofs are for verifying typesetting, editing, completeness, and accuracy. Significant changes at this stage require journal editor approval. To expedite publication, please provide proof corrections within two days.
Publication Frequency
Global Diagnostics and Therapeutics in Medicine will adopt a continuous publication model, where articles will be published online as soon as they are peer-reviewed and copy-edited. Accepted papers will be promptly published online and included in the recently published articles section. This approach will ensure that research findings are disseminated quickly and efficiently, keeping the academic community up to date with the latest developments.
Authorship and Permissions
Name Change Policy
The journal respects authors’ rights to change their names for personal reasons, including identity, marital status, or religion. Authors can request confidential name changes after publication without a formal correction notice or explanation. If a public change is preferred, a correction notice can be issued with or without the reason, based on the author’s preference. The journal will update both online and PDF versions of the article and notify relevant indexes and databases, though the timing of these updates cannot be guaranteed.
Changes in Authorship
Authorships order should be agreed upon by all authors prior to manuscript submission, and any disputes should be resolved before submission. Changes to authorship, including modifications to the order, additions, or deletions of authors, must be approved by all co-authors. Requests for such changes after initial submission and before publication must be communicated in writing to the editor via a letter or email, with approval from all authors.
Personal Communications and Unpublished Data
For any personal communications or unpublished data referenced in your manuscript, a signed statement of permission must be obtained from the individual providing the information. The statement should specify the date of the communication and indicate whether it was written or oral. Personal communications should not be listed in the references but should instead be cited in parentheses in the text.
Permissions
If authors wish to include previously published figures, tables, or text in their manuscript, they must obtain permission from the copyright holder(s) for both print and online formats. Evidence of this permission must be provided at the time of submission. Material submitted without this evidence will be considered the authors’ original work.